Clinical Trial

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the protective effect of metformin on nephrotoxicity of cisplatin in patients with bladder cancer. The main questions it aims to answer are: * To determine protective effect of metformin on structural and functional kidney injury caused by cisplatin in patients with bladder cancer. * To evaluate the safety of combining cisplatin and metformin on patients with bladder cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-10.
Trial Details
NCT Number NCT06215976
Lead Sponsor Cairo University
Conditions Muscle-Invasive Bladder Carcinoma
Enrollment 78 participants
Start Date 2023-06-01
Primary Completion 2024-06-01 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-20